Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB401290

FFAR3/GPR41 Antibody (2590G) [DyLight 550], Novus Biologicals™
SDP

Catalog No. NB401290 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB401290 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB401290 Supplier Novus Biologicals Supplier No. FAB10562L
Add to Cart
Add to Cart

Description

Rabbit Monoclonal Antibody

FFAR3/GPR41 Monoclonal antibody specifically detects FFAR3/GPR41 in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF

Specifications

Antigen FFAR3/GPR41
Applications Western Blot, Flow Cytometry, CyTOF
Classification Monoclonal
Clone 2590G
Conjugate DyLight 550
Dilution Western Blot, Flow Cytometry, CyTOF-ready
Formulation 50mM Sodium Borate
Gene Alias free fatty acid receptor 3, G protein-coupled receptor 41, GPR41FFA3R, G-protein coupled receptor 41
Host Species Rabbit
Immunogen Synthetic peptide containing human FFAR3
Purification Method Protein A or G purified from cell culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline GPCR
Primary or Secondary Primary
Gene ID (Entrez) 2865
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.